Novel Therapeutic Regimens in Treating Ocular Surface Disease and Blepharitis

	Introduction Eric D. Donnenfeld, MD		Conventional Therapeutic Approach to Lid Margin Disease Edward J. Holland, MD
	Lid Margin Disease-Incidence, Etiology and Diagnosis Henry D Perry, MD		The Anti-Infectious and Anti-Inflammatory Effects of Azithromycin Terrence P. O Brien, MD
	The Surgical and Medical Impact of Lid Margin Disease Helen K. Wu, MD		Advanced Treatment of Blepharitis and the BETA Panel Recommendations Kerry D. Solomon, MD
	Importance of Improving the Ocular Surface on Surgical Outcomes Marguerite B. McDonald, MD